Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
586.00    0.00 (0.00%)
Bid:
583.00
Ask:
588.00
Spread: 5.00 (0.858%)
Market Cap: £1.08b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Half Year Trading Update

16 Oct 2025 07:00

RNS Number : 5631D
Volex PLC
16 October 2025
 

16 October 2025

 

Volex plc

("Volex", the "Company", or the "Group")

 

Half Year Trading Update

 

Strong performance with revenue momentum maintained and continued margin resilience; full year expectations unchanged

 

Volex (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today releases a trading update for the 6 months ended 30 September 2025 (the "period").

 

The Group delivered a strong first half result, maintaining the performance and momentum delivered in the second half of FY2025, which underlines the continued resilience of the business.

 

Revenues are expected to exceed $575 million with organic revenue growth for the period of at least 11%, driven by the Group's product offering and long-standing relationships with blue-chip customers across five end-markets.

 

Electric Vehicles grew strongly year-on-year due to our increasingly diverse range of products and customers. As expected, Medical demand was subdued as customers assessed the implications of lower spend in healthcare and research and adjusted inventory levels accordingly.

 

Consumer Electricals revenue was similar to H2 FY2025 but down on an organic basis against a strong H1 FY2025 comparative. Off-Highway delivered strong growth, benefiting from a one-off customer project that was delivered in the first half. Complex Industrial Technology grew significantly with data centre demand showing a very strong increase relative to H1 FY2025.

 

Margin resilience supports continued investment in customer-led growth

 

Operating profit margin for the first half is expected to remain within the upper half of the Board's through-cycle target range of 9-10%. Our consistent margin delivery validates the Group's ability to navigate regional cost pressures whilst balancing continued investment in capacity and capabilities to support our customers' evolving needs.

 

The ongoing evolution in the trading environment as a consequence of tariffs remains an opportunity for Volex, and the Group has been working closely with several key customers who in response, are reconfiguring their global production footprints. These activities are strengthening Volex's customer relationships and improving our competitive positioning for the medium term. A small number of new programme launches have been temporarily deferred in both the Complex Industrial Technology and Electric Vehicles end-markets as a result of relocating manufacturing to support our customers, with these projects expected to be delivered in FY2027 and beyond.

 

Outlook

 

The Group expects second-half revenues to be broadly similar to the first half, reflecting stable trading across most end-markets. 

 

Volex continues to demonstrate operational discipline, cost control and margin consistency which provides the Board with confidence in making further progress towards its five-year plan targets. With a strong balance sheet, significant undrawn facilities and access to funding, the Group is well-positioned to pursue value-accretive acquisitions that meet our investment criteria.

 

Structural demand in key markets, a diversified customer base, and continued investment in capability expansion underpin the Group's confidence in delivering strong returns for all stakeholders, despite a challenging macro-economic environment. The Board's expectations for the full year remain unchanged.

 

Half year results

 

The Group expects to release its interim results on 12 November 2025.

 

 

-ENDS-

 

For further information please contact:

 

Volex plc +44 (0) 1256 442570

Nat Rothschild, Executive Chairman investor.relations@volex.com

Jon Boaden, Chief Financial Officer

Peel Hunt LLP - Nominated Adviser & Joint Broker +44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Tom Graham

 

Jefferies - Joint Broker +44 (0) 20 7029 8000

Philip NobletSam Barnett

Harry Le May

 

Sodali & Co. - Media Enquiries +44 (0) 20 7250 1446

James WhiteNicholas Johnson

 About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 25 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

Forward looking statements

This announcement contains certain forward-looking statements which have been made by the Directors in good faith using information available up until the date they approved the announcement. Forward-looking statements should be regarded with caution as, by their nature, such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFWFWIEISESS
Date   Source Headline
7th Dec 20233:42 pmRNSScrip Reference Price
23rd Nov 20237:00 amRNSHalf-year report
8th Nov 20237:15 amRNSAnalyst Briefing & Investor Presentation
24th Oct 20237:00 amRNSUpdate on H1 Trading and Cyber Incident
20th Oct 20237:00 amRNSDirectorate Changes
9th Oct 20237:00 amRNSNotice of Cyber Incident
28th Sep 20237:00 amRNSHolding(s) in Company
1st Sep 20237:00 amRNSCompletion of Murat Ticaret Acquisition
30th Aug 20235:00 pmRNSDirector/PDMR Shareholding
21st Aug 20234:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20237:00 amRNSReceipt of Competition Clearance for Murat Ticaret
27th Jul 20236:23 pmRNSResult of AGM
27th Jul 202311:37 amRNSScrip Reference Price
27th Jul 20237:00 amRNSAGM Statement
19th Jul 20237:00 amRNSDirector/PDMR Shareholding
30th Jun 20234:40 pmRNSDirector/PDMR Shareholding
28th Jun 20234:59 pmRNSHolding(s) in Company
27th Jun 202310:00 amRNSNotice of AGM and Publication of Annual Report
22nd Jun 20231:00 pmRNSResults of Fundraising
22nd Jun 20237:02 amRNSREX Retail Offer
22nd Jun 20237:01 amRNSAcquisition of Murat Ticaret and Proposed Placing
22nd Jun 20237:00 amRNSPreliminary Group Results FY2023
12th Jun 20237:00 amRNSNotice of Results and Investor Presentation
18th May 20237:00 amRNSChange of Adviser
27th Apr 20237:00 amRNSEV Contract Win
18th Apr 20237:00 amRNSFull Year Trading Update
18th Jan 20237:00 amRNSAnalyst Site Visit
22nd Dec 202210:03 amRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20227:00 amRNSScrip Reference Price
9th Nov 20227:00 amRNSHalf-year Report of Volex plc
13th Oct 20227:00 amRNSNotice of Half Year Results
1st Sep 20227:00 amRNSTotal Voting Rights
31st Aug 20223:58 pmRNSDirector / PDMR Dealing
30th Aug 20223:36 pmRNSDirector / PDMR Dealing
19th Aug 20225:32 pmRNSResults of AGM, Issue of Equity and TVR
19th Aug 20227:00 amRNSAGM Statement
29th Jul 20224:00 pmRNSScrip Dividend Scheme and Scrip Reference Price
11th Jul 202210:53 amRNSNotice of AGM and Publication of Annual Report
29th Jun 20225:08 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSPreliminary Group Results FY2022
8th Jun 20227:00 amRNSNotice of Preliminary Results & IMC Presentation
19th May 20227:00 amRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSCompletion of inYantra acquisition
20th Apr 20227:00 amRNSTrading Update
12th Apr 202212:38 pmRNSHolding(s) in Company
6th Apr 202210:42 amRNSHolding(s) in Company
15th Mar 202211:14 amRNSPDMR / PCA Dealing
8th Mar 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.